Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group.
Africa
Anti-epileptic treatment
Discrimination
Epilepsy
Misconception
Nodding syndrome
Onchocerciasis
Stigma
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
20 May 2019
20 May 2019
Historique:
received:
06
12
2018
accepted:
21
04
2019
entrez:
22
5
2019
pubmed:
22
5
2019
medline:
30
6
2019
Statut:
epublish
Résumé
In onchocerciasis-endemic areas, particularly in those with a sub-optimal onchocerciasis control programme, a high prevalence of epilepsy is observed. Both onchocerciasis and epilepsy are stigmatizing conditions. The first international workshop on onchocerciasis-associated epilepsy (OAE) was held in Antwerp, Belgium (12-14 October 2017) and during this meeting, an OAE alliance was established. In this paper, we review what is known about epilepsy-associated stigma in onchocerciasis-endemic regions, and present the recommendations of the OAE alliance working group on stigma. For this scoping review, literature searches were performed on the electronic databases PubMed, Scopus and Science Direct using the search terms "epilepsy AND onchocerciasis AND stigma". Hand searches were also undertaken using Google Scholar, and in total seven papers were identified that addressed epilepsy-related stigma in an onchocercisasis-endemic area. Due to the limited number of published research papers on epilepsy-associated stigma in onchocerciasis-endemic areas, other relevant literature that describes important aspects related to stigma is discussed. The thematic presentation of this scoping review follows key insights on the barriers to alleviating the social consequences of stigma in highly affected onchocerciasis-endemic areas, which were established by experts during the working group on stigma and discrimination at the first international workshop on OAE. These themes are: knowledge gaps, perceived disease aetiology, access to education, marriage restrictions, psycho-social well-being, burden on the care-giver and treatment seeking behaviour. Based on the literature and expert discussions during the OAE working group on stigma, this paper describes important issues regarding epilepsy-related stigma in onchocerciasis-endemic regions and recommends interventions that are needed to reduce stigma and discrimination for the improvement of the psycho-social well-being of persons with epilepsy. Educating healthcare workers and communities about OAE, strengthening onchocerciasis elimination programs, decreasing the anti-epileptic treatment gap, improving the care of epilepsy-related injuries, and prioritising epilepsy research is the way forward to decreasing the stigma associated with epilepsy in onchocerciasis-endemic regions.
Sections du résumé
BACKGROUND
BACKGROUND
In onchocerciasis-endemic areas, particularly in those with a sub-optimal onchocerciasis control programme, a high prevalence of epilepsy is observed. Both onchocerciasis and epilepsy are stigmatizing conditions. The first international workshop on onchocerciasis-associated epilepsy (OAE) was held in Antwerp, Belgium (12-14 October 2017) and during this meeting, an OAE alliance was established. In this paper, we review what is known about epilepsy-associated stigma in onchocerciasis-endemic regions, and present the recommendations of the OAE alliance working group on stigma.
MAIN BODY
METHODS
For this scoping review, literature searches were performed on the electronic databases PubMed, Scopus and Science Direct using the search terms "epilepsy AND onchocerciasis AND stigma". Hand searches were also undertaken using Google Scholar, and in total seven papers were identified that addressed epilepsy-related stigma in an onchocercisasis-endemic area. Due to the limited number of published research papers on epilepsy-associated stigma in onchocerciasis-endemic areas, other relevant literature that describes important aspects related to stigma is discussed. The thematic presentation of this scoping review follows key insights on the barriers to alleviating the social consequences of stigma in highly affected onchocerciasis-endemic areas, which were established by experts during the working group on stigma and discrimination at the first international workshop on OAE. These themes are: knowledge gaps, perceived disease aetiology, access to education, marriage restrictions, psycho-social well-being, burden on the care-giver and treatment seeking behaviour. Based on the literature and expert discussions during the OAE working group on stigma, this paper describes important issues regarding epilepsy-related stigma in onchocerciasis-endemic regions and recommends interventions that are needed to reduce stigma and discrimination for the improvement of the psycho-social well-being of persons with epilepsy.
CONCLUSIONS
CONCLUSIONS
Educating healthcare workers and communities about OAE, strengthening onchocerciasis elimination programs, decreasing the anti-epileptic treatment gap, improving the care of epilepsy-related injuries, and prioritising epilepsy research is the way forward to decreasing the stigma associated with epilepsy in onchocerciasis-endemic regions.
Identifiants
pubmed: 31109376
doi: 10.1186/s40249-019-0544-6
pii: 10.1186/s40249-019-0544-6
pmc: PMC6526597
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
34Subventions
Organisme : European Research Council
ID : ERCPoC 768815
Pays : International
Organisme : Vlaamse Instelling voor Technologisch Onderzoek
ID : SOFI 2014-2017
Références
Epilepsia. 1999 Mar;40(3):382-6
pubmed: 10080524
Med Anthropol. 2001;19(4):355-82
pubmed: 11800319
Epilepsia. 2002 May;43(5):535-8
pubmed: 12027916
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
J Neurol Sci. 2003 May 15;209(1-2):65-8
pubmed: 12686404
Isr Med Assoc J. 2003 Jul;5(7):522-3
pubmed: 12901252
Soc Sci Med. 1992 Mar;34(6):657-66
pubmed: 1574733
Epilepsy Behav. 2005 Aug;7(1):68-73
pubmed: 15978874
Lancet Neurol. 2007 Jan;6(1):39-44
pubmed: 17166800
Br J Psychiatry. 2007 Mar;190:192-3
pubmed: 17329736
Epilepsy Behav. 2009 Jan;14(1):83-8
pubmed: 18845276
Epilepsy Res. 2008 Dec;82(2-3):200-10
pubmed: 18976884
Epilepsia. 2009 May;50(5):1296-9
pubmed: 19496813
Epilepsia. 2009 May;50(5):1262-5
pubmed: 19507307
PLoS Negl Trop Dis. 2009 Jun 16;3(6):e461
pubmed: 19529767
J Neurol Sci. 2009 Oct 15;285(1-2):149-53
pubmed: 19631349
Epilepsia. 2009 Sep;50(9):2167-8
pubmed: 19706061
Epilepsy Behav. 2009 Oct;16(2):254-9
pubmed: 19751991
Epilepsy Behav. 2010 Jan;17(1):95-102
pubmed: 19932640
Epilepsy Behav. 2010 Mar;17(3):381-8
pubmed: 20153701
Seizure. 2010 Dec;19(10):630-6
pubmed: 21075013
Epilepsy Behav. 2011 Sep;22(1):55-62
pubmed: 21458385
Am J Trop Med Hyg. 2012 Mar;86(3):557
pubmed: 22403337
Trans R Soc Trop Med Hyg. 2012 Jun;106(6):340-7
pubmed: 22513165
Lancet Neurol. 2013 Feb;12(2):166-74
pubmed: 23305742
Epilepsy Behav. 2013 Apr;27(1):188-92
pubmed: 23454914
Seizure. 2013 May;22(4):299-302
pubmed: 23473634
Ethn Health. 2014 Feb;19(1):100-18
pubmed: 23489117
PLoS Negl Trop Dis. 2013;7(3):e2147
pubmed: 23556028
BMJ Open. 2013 May 03;3(5):null
pubmed: 23645924
Emerg Infect Dis. 2013;19(9):1374-84
pubmed: 23965548
Epilepsy Behav. 2013 Nov;29(2):316-21
pubmed: 24025488
Afr Health Sci. 2013 Jun;13(2):176-82
pubmed: 24235914
Afr Health Sci. 2013 Jun;13(2):219-32
pubmed: 24235917
Afr Health Sci. 2013 Jun;13(2):529-40
pubmed: 24235964
Afr Health Sci. 2013 Sep;13(3):613-23
pubmed: 24250298
Epilepsy Res. 2014 Feb;108(2):316-26
pubmed: 24300028
Epilepsy Behav. 2014 Apr;33:115-21
pubmed: 24657502
Lancet Neurol. 2014 Oct;13(10):1029-44
pubmed: 25231525
Glob Health Action. 2014 Oct 21;7:25069
pubmed: 25361725
BMJ Open. 2014 Nov 14;4(11):e006476
pubmed: 25398677
Pan Afr Med J. 2014 Jul 27;18:255
pubmed: 25489360
Epilepsy Behav. 2015 Jan;42:71-7
pubmed: 25500358
Springerplus. 2014 Dec 23;3:762
pubmed: 25674487
Epilepsy Behav. 2015 May;46:126-32
pubmed: 25936276
Epilepsy Behav. 2016 Jan;54:7-11
pubmed: 26610095
Int J Infect Dis. 2016 Apr;45:112-7
pubmed: 26987477
BMC Res Notes. 2016 Mar 22;9:182
pubmed: 27005304
PLoS Negl Trop Dis. 2016 May 03;10(5):e0004478
pubmed: 27139245
Trends Parasitol. 2016 Aug;32(8):581-583
pubmed: 27289272
Sci Transl Med. 2017 Feb 15;9(377):
pubmed: 28202778
J Int AIDS Soc. 2017 Jan 10;20(1):21395
pubmed: 28362067
PLoS Negl Trop Dis. 2017 Jul 14;11(7):e0005732
pubmed: 28708828
Anthropol Med. 2017 Oct 30;:1-20
pubmed: 29081237
Seizure. 2018 Jan;54:27-32
pubmed: 29195225
Trends Parasitol. 2018 Mar;34(3):208-216
pubmed: 29288080
Infect Dis Poverty. 2018 Mar 22;7(1):23
pubmed: 29580280
Epilepsia Open. 2017 Apr 26;2(2):145-152
pubmed: 29588943
Epilepsy Behav. 2018 Aug;85:21-27
pubmed: 29906697
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319
Infect Dis Poverty. 2018 Aug 1;7(1):68
pubmed: 30064504
Infect Dis Poverty. 2018 Sep 19;7(1):101
pubmed: 30253788
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
Epilepsy Behav. 2019 Jan;90:295
pubmed: 30282593
Seizure. 2018 Nov;62:108-115
pubmed: 30340162
Seizure. 2018 Dec;63:93-101
pubmed: 30468964
Infect Dis Poverty. 2018 Dec 3;7(1):114
pubmed: 30501640
Infect Dis Poverty. 2018 Dec 4;7(1):115
pubmed: 30509330
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Int J Infect Dis. 2019 Feb;79:187-194
pubmed: 30711145
Epilepsia. 1979 Dec;20(6):613-22
pubmed: 499114
Afr J Med Sci. 1970 Jul;1(3):305-7
pubmed: 5521687
East Afr Med J. 1968 Jan;45(1):27-31
pubmed: 5649590
Epilepsia. 1980 Aug;21(4):433-44
pubmed: 7398608
Cent Afr J Med. 1994 Jan;40(1):13-8
pubmed: 8082145
Soc Sci Med. 1994 Jan;38(2):269-74
pubmed: 8140453
Epilepsia. 1993 Nov-Dec;34(6):1017-23
pubmed: 8243350
Epilepsy Res. 1998 May;30(3):247-51
pubmed: 9657652
Soc Sci Med. 1998 Oct;47(7):841-52
pubmed: 9722105
Ann Trop Med Parasitol. 1998 Apr;92 Suppl 1:S85-96
pubmed: 9861273